Publication | Open Access
Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes
148
Citations
29
References
2007
Year
ADMA predicted cardiovascular events and enhanced the predictive role of CRP in patients with type 2 diabetes. ADMA therefore could improve cardiovascular risk assessment in patients with type 2 diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1